Detalhe da pesquisa
1.
HA-1-targeted T cell receptor (TCR) T cell therapy for recurrent leukemia after hematopoietic stem cell transplantation.
Blood
; 2024 Apr 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38683966
2.
Conditioning intensity and peritransplant flow cytometric MRD dynamics in adult AML.
Blood
; 139(11): 1694-1706, 2022 03 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-34995355
3.
Role of chimeric antigen receptor T-cell therapy: bridge to transplantation or stand-alone therapy in pediatric acute lymphoblastic leukemia.
Curr Opin Hematol
; 28(6): 373-379, 2021 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34508031
4.
CD19 occupancy may drive CARs further.
Blood
; 143(3): 190-192, 2024 Jan 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38236611
5.
Development of T-cell immunotherapy for hematopoietic stem cell transplantation recipients at risk of leukemia relapse.
Blood
; 131(1): 108-120, 2018 01 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29051183
6.
Alternative immune effector cells picking up speed.
Mol Ther
; 32(3): 563-564, 2024 Mar 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38340733
7.
MDM2 inhibition augments GVL effect.
Blood
; 140(10): 1064-1065, 2022 09 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36074535
8.
Intent-to-treat leukemia remission by CD19 CAR T cells of defined formulation and dose in children and young adults.
Blood
; 129(25): 3322-3331, 2017 06 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-28408462
9.
Cytomegalovirus-specific T cells are primed early after cord blood transplant but fail to control virus in vivo.
Blood
; 121(14): 2796-803, 2013 Apr 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-23412093
10.
Engineering human peripheral blood stem cell grafts that are depleted of naïve T cells and retain functional pathogen-specific memory T cells.
Biol Blood Marrow Transplant
; 20(5): 705-16, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24525279
11.
Cyclin-A1 represents a new immunogenic targetable antigen expressed in acute myeloid leukemia stem cells with characteristics of a cancer-testis antigen.
Blood
; 119(23): 5492-501, 2012 Jun 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-22529286
12.
Discovery of U2AF1 neoantigens in myeloid neoplasms.
J Immunother Cancer
; 11(12)2023 12 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38164756
13.
NY-ESO-1 is a ubiquitous immunotherapeutic target antigen for patients with myxoid/round cell liposarcoma.
Cancer
; 118(18): 4564-70, 2012 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-22359263
14.
Leukemia-associated minor histocompatibility antigen discovery using T-cell clones isolated by in vitro stimulation of naive CD8+ T cells.
Blood
; 115(23): 4923-33, 2010 Jun 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-20203263
15.
The B-cell tumor-associated antigen ROR1 can be targeted with T cells modified to express a ROR1-specific chimeric antigen receptor.
Blood
; 116(22): 4532-41, 2010 Nov 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-20702778
16.
Hematopoietic Cell Transplantation after CD19 Chimeric Antigen Receptor T Cell-Induced Acute Lymphoblastic Lymphoma Remission Confers a Leukemia-Free Survival Advantage.
Transplant Cell Ther
; 28(1): 21-29, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34644605
17.
Utility of the Treatment-Related Mortality (TRM) score to predict outcomes of adults with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation.
Leukemia
; 36(6): 1563-1574, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35440690
18.
Hematopoietic Cell Transplantation in the Treatment of Pediatric Acute Myelogenous Leukemia and Myelodysplastic Syndromes: Guidelines from the American Society of Transplantation and Cellular Therapy.
Transplant Cell Ther
; 28(9): 530-545, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35717004
19.
Naive T-Cell Depletion to Prevent Chronic Graft-Versus-Host Disease.
J Clin Oncol
; 40(11): 1174-1185, 2022 04 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35007144
20.
Targeting an alternate Wilms' tumor antigen 1 peptide bypasses immunoproteasome dependency.
Sci Transl Med
; 14(631): eabg8070, 2022 02 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35138909